55 related articles for article (PubMed ID: 9076814)
1. WITHDRAWN: Ribavirin for respiratory syncytial virus infection of the lower respiratory tract in infants and young children.
Ventre K; Randolph A
Cochrane Database Syst Rev; 2010 May; 2010(5):CD000181. PubMed ID: 20464715
[TBL] [Abstract][Full Text] [Related]
2. Assessing the Burden of Respiratory Syncytial Virus-related Bronchiolitis in Primary Care and at 15-Day and 6-Month Follow-up Before Prophylaxis in France: A Test-negative Study.
Rybak A; Cohen R; Bangert M; Kramer R; Delobbe JF; Deberdt P; Cahn-Sellem F; Béchet S; Levy C
Pediatr Infect Dis J; 2024 Jul; 43(7):657-662. PubMed ID: 38900603
[TBL] [Abstract][Full Text] [Related]
3. Low incidence of severe respiratory syncytial virus infections in lung transplant recipients despite the absence of specific therapy.
Uçkay I; Gasche-Soccal PM; Kaiser L; Stern R; Mazza-Stalder J; Aubert JD; van Delden C
J Heart Lung Transplant; 2010 Mar; 29(3):299-305. PubMed ID: 19837611
[TBL] [Abstract][Full Text] [Related]
4. Nirsevimab Effectiveness Against Cases of Respiratory Syncytial Virus Bronchiolitis Hospitalised in Paediatric Intensive Care Units in France, September 2023-January 2024.
Paireau J; Durand C; Raimbault S; Cazaubon J; Mortamet G; Viriot D; Milesi C; Daudens-Vaysse E; Ploin D; Tessier S; Vanel N; Chappert JL; Levieux K; Ollivier R; Daoudi J; Coignard B; Leteurtre S; Parent-du-Châtelet I; Vaux S
Influenza Other Respir Viruses; 2024 Jun; 18(6):e13311. PubMed ID: 38840301
[TBL] [Abstract][Full Text] [Related]
5. Epidemiological Features of Bronchiolitis in the Pediatric Clinic of Clinical center of Sarajevo University.
Bakalovic G; Dzinovic A; Baljic R; Dizdar S; Selimovic A
Mater Sociomed; 2015 Jun; 27(3):154-7. PubMed ID: 26236159
[TBL] [Abstract][Full Text] [Related]
6. Management of Respiratory Syncytial Virus Bronchiolitis: 2015 Survey of Members of the European Society for Paediatric Infectious Diseases.
Carande EJ; Pollard AJ; Drysdale SB
Can J Infect Dis Med Microbiol; 2016; 2016():9139537. PubMed ID: 27840650
[TBL] [Abstract][Full Text] [Related]
7. Airway disease in hematologic malignancies.
José RJ; Dickey BF; Sheshadri A
Expert Rev Respir Med; 2022 Mar; 16(3):303-313. PubMed ID: 35176948
[TBL] [Abstract][Full Text] [Related]
8. Antiviral agents against respiratory viruses.
Tremblay CL
Clin Microbiol Newsl; 2001 Nov; 23(21):163-170. PubMed ID: 32336851
[No Abstract] [Full Text] [Related]
9. Past, Present and Future Approaches to the Prevention and Treatment of Respiratory Syncytial Virus Infection in Children.
Simões EAF; Bont L; Manzoni P; Fauroux B; Paes B; Figueras-Aloy J; Checchia PA; Carbonell-Estrany X
Infect Dis Ther; 2018 Mar; 7(1):87-120. PubMed ID: 29470837
[TBL] [Abstract][Full Text] [Related]
10. Challenges and opportunities in developing respiratory syncytial virus therapeutics.
Simões EA; DeVincenzo JP; Boeckh M; Bont L; Crowe JE; Griffiths P; Hayden FG; Hodinka RL; Smyth RL; Spencer K; Thirstrup S; Walsh EE; Whitley RJ
J Infect Dis; 2015 Mar; 211 Suppl 1(Suppl 1):S1-S20. PubMed ID: 25713060
[TBL] [Abstract][Full Text] [Related]
11. Emerging drugs for respiratory syncytial virus infection.
Olszewska W; Openshaw P
Expert Opin Emerg Drugs; 2009 Jun; 14(2):207-17. PubMed ID: 19453286
[TBL] [Abstract][Full Text] [Related]
12. Animal pneumoviruses: molecular genetics and pathogenesis.
Easton AJ; Domachowske JB; Rosenberg HF
Clin Microbiol Rev; 2004 Apr; 17(2):390-412. PubMed ID: 15084507
[TBL] [Abstract][Full Text] [Related]
13. Prevention and treatment of respiratory syncytial virus bronchiolitis and postbronchiolitic wheezing.
Kimpen JL
Respir Res; 2002; 3 Suppl 1(Suppl 1):S40-5. PubMed ID: 12119057
[TBL] [Abstract][Full Text] [Related]
14. Respiratory Syncytial Virus: Update on Infection, Treatment, and Prevention.
Krilov LR
Curr Infect Dis Rep; 2001 Jun; 3(3):242-246. PubMed ID: 11384554
[TBL] [Abstract][Full Text] [Related]
15. Respiratory syncytial virus infection: immune response, immunopathogenesis, and treatment.
Domachowske JB; Rosenberg HF
Clin Microbiol Rev; 1999 Apr; 12(2):298-309. PubMed ID: 10194461
[TBL] [Abstract][Full Text] [Related]
16. Follow-up of children with respiratory syncytial virus bronchiolitis in 1986 and 1987: potential effect of ribavirin on long term pulmonary function. The Bronchiolitis Study Group.
Krilov LR; Mandel FS; Barone SR; Fagin JC
Pediatr Infect Dis J; 1997 Mar; 16(3):273-6. PubMed ID: 9076814
[TBL] [Abstract][Full Text] [Related]
17. Prospective follow-up and pulmonary functions from a placebo-controlled randomized trial of ribavirin therapy in respiratory syncytial virus bronchiolitis. Ribavirin Study Group.
Rodriguez WJ; Arrobio J; Fink R; Kim HW; Milburn C
Arch Pediatr Adolesc Med; 1999 May; 153(5):469-74. PubMed ID: 10323626
[TBL] [Abstract][Full Text] [Related]
18. Does ribavirin impact on the hospital course of children with respiratory syncytial virus (RSV) infection? An analysis using the pediatric investigators collaborative network on infections in Canada (PICNIC) RSV database.
Law BJ; Wang EE; MacDonald N; McDonald J; Dobson S; Boucher F; Langley J; Robinson J; Mitchell I; Stephens D
Pediatrics; 1997 Mar; 99(3):E7. PubMed ID: 9099772
[TBL] [Abstract][Full Text] [Related]
19. Reduced long-term respiratory morbidity after treatment of respiratory syncytial virus bronchiolitis with ribavirin in previously healthy infants: a preliminary report.
Edell D; Bruce E; Hale K; Edell D; Khoshoo V
Pediatr Pulmonol; 1998 Mar; 25(3):154-8. PubMed ID: 9556006
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
